論文(2013)

英文原著

  1. Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W, Li S, Clark RA, Ali SF: Neuroprotective efficacy of a new brain-penetrating c-Abl inhibitor in a murine Parkinsonʼs disease model. PLOS One 8, 65129, 2013.
  2. Jin L, Tabe Y, Kojima K, Shikami M, Benito J, Ruvolo V, Wang RY, McQueen T, Ciurea SO, Miida T, Andreeff M, Konopleva M: PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment. J Mol Med (Berl) 91(12), 1383-97, 2013.
  3. Katagiri S, Tauchi T, Okabe S, Minami Y, Kimura S, Maekawa T, Naoe T, Ohyashiki K: Targeting the hedgehog signaling pathway in therapy-resistant BCR-ABL1 positive leukemia with ponatinib. Clin Cancer Res 19(6), 1422-1432, 2013.
  4. Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S and Hayashi S: Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study. Biomark Insights 8, 97-105, 2013.
  5. Kimura S, Ando T, Kojima K: Ever-advancing chronic myeloid leukemia treatment. Int J Clin Oncol, 2013.Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mu- kai K, Tsukasaki K, Shimoyama M: Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG) Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Jpn J Clin Oncol 42, 394-404, 2012.
  6. Kojima K, Kornblau SM, Ruvolo V, Dilip A, Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, Qiu YH, Burks JK, Kantarjian H, Shacham S, Kauffman M, Andreeff M: Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood 121(20), 4166-74, 2013.
  7. Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, Hattori S, Kimura S, Okada S: Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. Bioorgan Med Chem Lett 23(3), 606-9, 2013.
  8. Miyahara T, Mochinaga S, Kimura S, Aragane N, Yakabe T, Morita S, Okudaira K, Fujito H: Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients. Cancer Chemother Pharmacol 71(1), 175-82, 2013.
  9. Nihon-Yanagi Y, Terai K, Murano T, Kawai T, Kimura S, Okazumi S: β-2 microglobulin is unsuitable as an internal reference for the analysis of gene expression in human colorectal cancer. Biomed Rep 1(2), 193-196, 2013.
  10. Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H, Ueki T, Nagafuji K, Kako S, Uoshima N, Tsudo M, Itamura H, Fukuda T: Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis ―1― after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 57(5), 671-81, 2013.
  11. Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T, Ohyashiki K: Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells. Cancer Cell Int 13 (1), 32, 2013.
  12. Shindo T, Kim TK, Benjamin CB, Wieder ED, Levy RB, Komanduri KV: MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-depenent manner (Plenary paper). Blood 121, 4617-4626, 2013.
  13. Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakamichi K, Tanimoto K: Development of lymphoproliferative diseases by hypoxia inducible factor-1 a is associated with prolonged lymphocyte survival. PLOS One 8 (4), e57833, 2013.
  14. Takahashi H, Mizuta T, Oeda S, Isoda H, Nakashita S, Kawaguchi Y, Izumi N, Hirai M, Kurose K, Iwane S, Eguchi Y, Kimura S, Anzai K, Ozaki I: An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C. J Viral Hepat 20(4), e124-126, 2013.
  15. Yamada K, Takayama K, Kawakami S, Saruwatari K, Morinaga R, Harada T, Aragane N, Nagata S, Kishimoto J, Nakanishi Y, Ichinose Y: Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK 0803). Jpn J Clin Oncol 43, 629-35, 2013.
  16. Yamakawa N, Ohto U, Akashi-Takamura S, Takahashi K, Saitoh S, Tanimura N, Suganami T, Ogawa Y, Shibata T, Shimizu T, Miyake K: Human TLR4 polymorphism D299 G/T399 I alters TLR 4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A. Int Immunol 25, 45-52, 2013.

英文症例報告 Letter to the editor

  1. Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, Aragane N, Yakushiji M, Yamamoto M, Aoki S, Toda S: Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis. Hum Pathol 44, 2614-8, 2013.
  2. Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S: Therapeutic management in cardiac lymphoma. Leuk Lymphoma. 2013, Sep 3. 2013.
  3. Yakabe T, Kitahara K, Komiya K, Sueoka-Aragane N, Kimura S, Sugioka T, Noshiro H: Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy. World J Surg Oncol 11, 167. 2013.

英文総説

  1. Vélez J, Hail N Jr, Konopleva M, Zeng Z, Kojima K, Samudio I, Andreeff M: Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells. Front Oncol. 2013 Apr 2, 3, 67, 2013.

日本語原著

  1. 末岡栄三朗,山田尚友,山田麻里江,久保田寧,浦田千紗子,吉村麻里子,板村英和,久富 崇,福 島伯泰,出 勝,横尾眞子,吉原麻里,蒲池和晴,北村浩晃,進藤岳郎,一戸辰夫,木村晋也: 輸血後鉄過剰症の現状と問題点.日本輸血・細胞治療学会誌 59(1),73‐78,2013.
 

日本語著書

  1. 木村晋也:慢性骨髄性白血病.今日の治療指針,(山口徹,北原光男,福井次矢編集).p607‐609, 医学書院.2013.
 

日本語総説

  1. 木村晋也:全自動遺伝子解析装置と肺がん治療.生物試料分析学会雑誌 36(3),245‐251,2013.
  2. 木村晋也:がん分子標的薬の開発,有効利用.九州薬学会会報 67,1‐6,2013.
  3. 木村晋也:新たな第2世代 ABL TKIs の基礎と臨床.血液内科 67(2),152‐158,2013.
  4. 木村晋也:ビスホスホネートによる骨転移治療.外来化学療法 4(1),13‐17,2013.
  5. 中村朝美,木村晋也:EGF 受容体の突然変異を検出する新しい鋭敏な方法.生体の科学 64(5), 464‐465,2013.
  6. 進藤岳郎,木村晋也:CML を目指した治療.血液フロンティア 23,217‐224,2013
  7. 荒金尚子 肺がんに対する分子標的治療 BIO Clinica 28 (1), 23-27, 2013

最終更新日:2015年4月16日

(C)佐賀大学医学部附属病院血液・呼吸器・腫瘍内科